In silico study on the substrate binding manner in human myo-inositol monophosphatase 2

被引:0
|
作者
Seisuke Fujita
Tetsuo Ohnishi
Shujiro Okuda
Ryo Kobayashi
Satoshi Fukuno
Daisuke Furuta
Takeshi Kikuchi
Takeo Yoshikawa
Norihisa Fujita
机构
[1] Ritusmeikan University,Laboratory of Pharmacoinformatics, School of Pharmacy
[2] RIKEN Brain Science Institute,Laboratory for Molecular Psychiatry
[3] Ritsumeikan University,Department of Bioinformatics, College of Information Science and Engineering
来源
关键词
AutoDock; Bipolar disorder; Enzyme-substrate docking; Human ; -inositol monophosphatase 2; Three-metal-ion theory;
D O I
暂无
中图分类号
学科分类号
摘要
The human IMPA2 gene encoding myo-inositol monophosphatase 2 is highly implicated with bipolar disorder but the substrates and the reaction mechanism of myo-inositol monophosphatase 2 have not been well elucidated.9 In the present study, we constructed 3D models of three- and two-Mg2+-ion bound myo-inositol monophosphatase 2, and studied substrate-binding manners using the docking program AutoDock3. The subsequent study showed that the three-metal-ion model could interact with myo-inositol monophosphates, as follows: The phosphate moiety coordinated three Mg2+ ions, and the inositol ring formed hydrogen bonds with the amino acids conserved in the family. Furthermore, the OH group vicinal to the phosphate group formed a hydrogen bond with a non-bridging oxygen atom of the phosphate. These interactions have been proposed as crucial for forming the transitional state, bipyramidal structure in the bovine myo-inositol monophosphatase. We therefore propose that the human myo-inositol monophosphatase 2 interacts with myo-inositol monophosphates in the three-metal-ion bound form, and proceeds the dephosphorylation through the three-metal-ion theory.
引用
收藏
页码:2559 / 2567
页数:8
相关论文
共 50 条
  • [41] Myo-inositol monophosphatase is an activated target of calbindin D28k
    Berggård, T
    Szczepankiewicz, O
    Thulin, E
    Linse, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) : 41954 - 41959
  • [42] Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples
    T Yoshikawa
    M Kikuchi
    K Saito
    A Watanabe
    K Yamada
    H Shibuya
    M Nankai
    A Kurumaji
    E Hattori
    H Ishiguro
    H Shimizu
    Y Okubo
    M Toru
    S D Detera-Wadleigh
    Molecular Psychiatry, 2001, 6 : 202 - 210
  • [43] Effects of myo-Inositol ingestion on human brain myo-inositol levels: A proton magnetic resonance spectroscopic imaging study
    Moore, CM
    Breeze, JL
    Kukes, TJ
    Rose, SL
    Dager, SR
    Cohen, BM
    Renshaw, PF
    BIOLOGICAL PSYCHIATRY, 1999, 45 (09) : 1197 - 1202
  • [44] Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment
    Dimitrova, A
    Milanova, V
    Krastev, S
    Nikolov, I
    Toncheva, D
    Owen, MJ
    Kirov, G
    PHARMACOGENOMICS JOURNAL, 2005, 5 (01): : 35 - 41
  • [45] Association study of myo-inositol monophosphatase 2 (IMPA2) polymophisms with bipolar affective disorder and response to lithium treatment
    Dimitrova, A
    Georgieva, L
    Nikolov, L
    Toncheva, D
    Owen, MJ
    Kirov, G
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 158 - 159
  • [46] Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment
    A Dimitrova
    V Milanova
    S Krastev
    I Nikolov
    D Toncheva
    M J Owen
    G Kirov
    The Pharmacogenomics Journal, 2005, 5 : 35 - 41
  • [47] Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures
    Arai, Ryoichi
    Ito, Kaori
    Ohnishi, Tetsuo
    Ohba, Hisako
    Akasaka, Ryogo
    Bessho, Yoshitaka
    Hanawa-Suetsugu, Kyoko
    Yoshikawa, Takeo
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 67 (03) : 732 - 742
  • [48] Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder
    Bloch, Paul J.
    Weller, Andrew E.
    Doyle, Glenn A.
    Ferraro, Thomas N.
    Berrettini, Wade H.
    Hodge, Rachel
    Lohoff, Falk W.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (08): : 1515 - 1519
  • [49] Synthesis and structure revision of the myo-inositol monophosphatase inhibitor L-671,776
    Falck, JR
    Reddy, KK
    Chandrasekhar, S
    TETRAHEDRON LETTERS, 1997, 38 (30) : 5245 - 5248
  • [50] High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy
    Gill, R
    Mohammed, F
    Badyal, R
    Coates, L
    Erskine, P
    Thompson, D
    Cooper, J
    Gore, M
    Wood, S
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 : 545 - 555